4.3 Article

Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata

Journal

JOURNAL OF DERMATOLOGICAL TREATMENT
Volume 33, Issue 1, Pages 324-328

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/09546634.2020.1752887

Keywords

Alopecia areata; diphencyprone; interferon gamma

Categories

Ask authors/readers for more resources

This study evaluated the effectiveness of DPCP in alopecia areata and identified prognostic factors and biomarkers associated with clinical response. The results showed that DPCP can reduce levels of specific cytokines and promote hair regrowth.
Introduction: Diphencyprone (DPCP) is considered as the first line of management in severe and extensive alopecia areata. The present study aims to evaluate the effectiveness of DPCP in alopecia areata and identify various prognostic factors and biomarkers associated with clinical response. Materials and methods: The study included participants with patchy and extensive alopecia areata (>30% scalp hair loss) treated with DPCP. Participants with Macdonald Hull and Norris grade 3 and 4 at the end of 6 months were considered as responders. We performed cytokine analysis prior and post-therapy. The protocol was registered with CTRI (REF/2017/09/015424). Results: The response rate was 54.5%. Longer disease duration, nail involvement, and high severity of alopecia tool (SALT) scores were associated with non-response. There was no significant difference in the cytokine levels among responders and non-responders before therapy. Among the responders, we found a significant decrease in IFN-gamma, IL-17A, IL-9, TGF-beta, and IL-13 except for IL-4, which significantly increased whereas, among the non-responders, only IL-17A and IL-13 levels have reduced considerably. Discussion: Diphencyprone reduced the level of Th1, Th17, and Th9 cytokines and increased the level of Th2 cytokines (IL-4) in the present study, which induced remission and promoted hair regrowth.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available